Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 98.42M | 99.01M | 95.58M | 90.63M | 84.19M | 78.01M |
Gross Profit | 92.91M | 93.53M | 90.25M | 85.53M | 79.78M | 73.87M |
EBITDA | 69.25M | 70.49M | 65.16M | 58.41M | 145.45M | 53.29M |
Net Income | 18.71M | 19.23M | 15.40M | 21.10M | 109.17M | 19.45M |
Balance Sheet | ||||||
Total Assets | 573.48M | 580.86M | 596.37M | 607.54M | 598.42M | 494.01M |
Cash, Cash Equivalents and Short-Term Investments | 6.97M | 7.10M | 8.21M | 7.61M | 22.50M | 5.74M |
Total Debt | 379.44M | 379.17M | 370.41M | 354.28M | 340.26M | 304.01M |
Total Liabilities | 401.32M | 401.32M | 395.44M | 378.44M | 363.09M | 335.00M |
Stockholders Equity | 172.17M | 179.54M | 200.93M | 229.10M | 235.33M | 159.00M |
Cash Flow | ||||||
Free Cash Flow | 45.77M | 46.91M | 35.32M | 33.19M | 34.74M | 41.94M |
Operating Cash Flow | 45.77M | 46.91M | 42.94M | 46.80M | 47.73M | 44.21M |
Investing Cash Flow | -6.83M | -13.88M | -19.11M | -36.67M | -24.43M | -27.21M |
Financing Cash Flow | -40.68M | -34.15M | -23.23M | -25.02M | -6.54M | -17.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | 1.39B | 35.29 | 2.91% | 6.37% | 0.43% | 58.57% | |
73 Outperform | 159.81M | 20.20 | 38.41% | 4.72% | 24.72% | 30.05% | |
63 Neutral | $542.34M | 30.20 | 10.08% | 7.55% | 0.14% | -0.76% | |
60 Neutral | 646.13M | 99.61 | 1.24% | 6.63% | 0.90% | ― | |
59 Neutral | 1.06B | -3.69 | -15.46% | 0.91% | 4.29% | 18.89% | |
52 Neutral | 426.92M | -38.88 | -1.69% | 12.46% | 2.96% | -877.53% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% |
On June 11, 2025, Universal Health Realty Income Trust, a company involved in real estate investment, held its Annual Meeting of Stockholders virtually. During the meeting, stockholders elected three Class III members to the Board of Trustees, approved a nonbinding advisory vote on executive compensation, and ratified KPMG, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. Additionally, the company granted long-term incentive awards in the form of restricted stock to its executive officers, with vesting scheduled for two years later, reflecting a continued focus on aligning executive compensation with long-term company performance.